zidovudine has been researched along with Vomiting in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blanche, S; Flynn, P; Giaquinto, C; Kakuda, TN; Komar, S; Lathouwers, E; Noguera-Julian, A; Opsomer, M; Van de Casteele, T; Welch, S | 1 |
Chaisson, RE; Charalambous, S; Churchyard, GJ; Fielding, KL; Grant, AD; Hoffmann, CJ; Innes, C; Sulkowski, MS; Thio, CL | 1 |
Cross, A; Dellamonica, P; Dunkle, L; Gathe, J; Jemsek, JG; Mellors, JW; Murphy, R; Pavia, AT; Spruance, SL; Stool, E | 1 |
Asavapiriyanont, S; Bhadrakom, C; Hannon, WH; Mastro, TD; Mei, JV; Moore, KH; Sangtaweesin, V; Shaffer, N; Simonds, RJ; Vanprapar, N; Young, NL | 1 |
Bozzette, S; Connor, JD; Dieterich, D; Hochster, H; Liebes, L; Pettinelli, C; Reichman, RC; Sonke, RL; Spector, SA; Valentine, F | 1 |
5 trial(s) available for zidovudine and Vomiting
Article | Year |
---|---|
Efficacy and safety of darunavir/ritonavir at 48 weeks in treatment-naïve, HIV-1-infected adolescents: results from a phase 2 open-label trial (DIONE).
Topics: Adolescent; Anemia; CD4 Lymphocyte Count; Darunavir; Dideoxynucleosides; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Male; Medication Adherence; Nausea; Neutropenia; Reverse Transcriptase Inhibitors; Ritonavir; Sulfonamides; Time Factors; Viral Load; Vomiting; Zidovudine | 2014 |
Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical events.
Topics: Adult; Alkynes; Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cohort Studies; Cyclopropanes; Developing Countries; Dizziness; Drug Tolerance; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Nausea; Neutropenia; Prospective Studies; South Africa; Treatment Outcome; Viral Load; Vomiting; Zidovudine | 2008 |
Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients. A randomized, double-blind, controlled trial. Bristol-Myers Squibb Stavudine/019 Study Group.
Topics: Adult; Anemia; Anti-HIV Agents; CD4 Lymphocyte Count; Disease Progression; Double-Blind Method; Female; HIV Infections; Humans; Male; Nausea; Neutropenia; Stavudine; Vomiting; Zidovudine | 1997 |
Oral zidovudine during labor to prevent perinatal HIV transmission, Bangkok: tolerance and zidovudine concentration in cord blood. Bangkok Collaborative Perinatal HIV Transmission Study Group.
Topics: Administration, Oral; Adult; Anti-HIV Agents; Cross-Sectional Studies; Female; Fetal Blood; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Labor, Obstetric; Nausea; Pregnancy; Pregnancy Complications, Infectious; Radioimmunoassay; Thailand; Viral Load; Vomiting; Zidovudine | 2000 |
Toxicity of combined ganciclovir and zidovudine for cytomegalovirus disease associated with AIDS. An AIDS Clinical Trials Group Study.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Anemia; Chemical and Drug Induced Liver Injury; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Ganciclovir; Humans; Leukopenia; Male; Middle Aged; Multicenter Studies as Topic; Neutropenia; Prospective Studies; Time Factors; Vomiting; Zidovudine | 1990 |